XML 30 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net (loss) income $ (161,683) $ 25,481
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 7,033 9,795
Stock-based compensation expense 6,599 8,398
Inventory impairments and option contract abandonments 28,145 24,281
Impairment of future land purchase right 4,036  
Deferred income tax benefit (185) (4,063)
Provision for doubtful accounts 161 (3,972)
Excess tax benefit from equity-based compensation 544 2,057
Equity in loss of unconsolidated joint ventures 141 24,045
Cash distributions of income from unconsolidated joint ventures 38 75
Loss (gain) on extinguishment of debt 2,343 (44,602)
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 301 (1,533)
Decrease (increase) in income tax receivable 4,849 (31,014)
(Increase) decrease in inventory (150,612) 20,442
Decrease in other assets 3,391 6,728
Increase (decrease) in trade accounts payable 15,803 (3,251)
Decrease in other liabilities (38,012) (31,626)
Other changes (510) (464)
Net cash (used in) provided by operating activities (277,618) 777
Cash flows from investing activities:    
Capital expenditures (12,134) (6,658)
Investments in unconsolidated joint ventures (1,763) (5,122)
Increases in restricted cash (250,074) (26,250)
Decreases in restricted cash 4,950 33,103
Net cash used in investing activities (259,021) (4,927)
Cash flows from financing activities:    
Repayment of debt (213,755) (617,133)
Proceeds from issuance of new debt 246,387 373,238
Proceeds from issuance of cash secured loan 247,368  
Debt issuance costs (5,130) (9,296)
Common stock redeemed (163) (134)
Common stock issued   166,719
Proceeds from the issuance of TEU prepaid stock purchase contracts   57,432
Excess tax benefit from equity-based compensation (544) (2,057)
Net cash provided by (used in) financing activities 274,163 (31,231)
Decrease in cash and cash equivalents (262,476) (35,381)
Cash and cash equivalents at beginning of period 537,121 507,339
Cash and cash equivalents at end of period $ 274,645 $ 471,958